A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load

American Journal of Geriatric Psychiatry

Volumn 24, Issue 10, 2016, Pages 804-813

  Loewenstein, David A ^a,b   Curiel, Rosie E ^a   Greig, Maria T ^b   Bauer, Russell M ^c   Rosado, Marian ^a   Bowers, Dawn ^c   Wicklund, Meredith ^c   Crocco, Elizabeth ^a   Pontecorvo, Michael ^e   Joshi, Abhinay D ^e   Rodriguez, Rosemarie ^b   Barker, Warren W ^b   Hidalgo, Jacqueline ^b   Duara, Ranjan ^b,c,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^e AVID RADIOPHARMACEUTICALS   (United States)

Author keywords

amyloid; LASSI L; MCI; PreMCI; proactive interference recovery

Indexed keywords

AMYLOID; FLORBETAPIR F 18; ANILINE DERIVATIVE; ETHYLENE GLYCOL DERIVATIVE; FLORBETAPIR; FLUORINE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; BOLUS INJECTION; BRAIN; BRAIN SCINTISCANNING; COGNITIVE DEFECT; COGNITIVE FUNCTION TEST; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; DIAGNOSTIC TEST ACCURACY STUDY; EXERCISE TEST; FEMALE; FISHER EXACT TEST; HUMAN; LEARNING TEST; LOEWENSTEIN ACEVEDO SCALE FOR SEMANTIC INTERFERENCE AND LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROACTIVE SEMANTIC INTERFERENCE; PSYCHOLOGICAL RATING SCALE; RETROACTIVE SEMANTIC INTERFERENCE; SCORING SYSTEM; SEMANTIC MEMORY; SEMANTICS; SUBJECTIVE MEMORY IMPAIRMENT; DIAGNOSTIC IMAGING; INDEPENDENT LIVING; MENTAL STRESS; METABOLISM; MIDDLE AGED; PRODROMAL SYMPTOM; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; ANILINE COMPOUNDS; BRAIN; COGNITIVE DYSFUNCTION; ETHYLENE GLYCOLS; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; INDEPENDENT LIVING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PLAQUE, AMYLOID; POSITRON-EMISSION TOMOGRAPHY; PRODROMAL SYMPTOMS; STRESS, PSYCHOLOGICAL;

EID: 84994908274     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2016.02.056     Document Type: Article

References (25)

1. 1 Rentz, D.M., Parra Rodriguez, M.A., Amariglio, R., et al. Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review. Alzheimers Res Ther, 5, 2013, 58.
2. 2 Brooks, L., Loewenstein, D., Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions. Alzheimers Res Ther, 2, 2010, 28.
3. 3 Sperling, R., Aisen, P., Beckett, L., et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 (2011), 280–292.
4. 4 Papp, K., Rentz, D., Mormino, E., et al. The neuropsychology of preclinical Alzheimer's disease: differential sensitivity of component processes of memory performance on biomarker evidence of amyloidosis. Neuropsychologia 73 (2015), 69–175.
5. 5 Loewenstein, D.A., Greig, M.T., Curiel, R., et al. Proactive semantic interference is associated with total and regional abnormal amyloid load in non-demented community-dwelling older adults. Am J Geriatr Psychiatry 23 (2015), 1276–1279.
6. 6 Curiel, R., Crocco, E., Acevedo, A., et al. A new scale for the evaluation of proactive and retroactive interference in mild cognitive impairment and early Alzheimer's disease. J Aging Sci, 1, 2013.
7. 7 Crocco, E., Curiel, R., Acevedo, A., et al. An evaluation of deficits in semantic cueing and proactive and retroactive interference as early features of Alzheimer's disease. Am J Geriatr Psychiatry 22 (2014), 889–897.
8. 8 Duara, R., Loewenstein, D., Potter, E., et al. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates. Am J Geriatr Psychiatry 19 (2011), 951–960.
9. 9 Loewenstein, D., Greig, M., Schinka, J., et al. An investigation of PreMCI: subtypes and longitudinal outcomes. Alzheimers Dement 8 (2012), 172–179.
10. 10 Sperling, R.A., Johnson, K., Doraiswamy, P.M., et al. Amyloid deposition detected with florbetapir F 18 PET (18F-AV-45) is related to lower episodic memory performance in clinically normal individuals. Neurobiol Aging 34 (2013), 822–831.
11. 11 Joshi, A.D., Pontecorvo, M.J., Lu, M., et al. A semi-automated method for quantification of florbetapir F 18 PET images. J Nucl Med, 2015, 10.2967/jnumed.114.153494 in press.
12. 12 Clark, C.M., Schneider, J.A., Bedell, B.J., et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 305 (2011), 275–283.
13. 13 Villeneuve, S., Rabinovici, G.D., Cohn-Sheehy, B.I., et al. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain 138 (2015), 2020–2033.
14. 14 Leuzy, A., Zimmer, E.R., Gauthier, S., et al. Amyloid imaging in Alzheimer's disease: a potential new era in personalized medicine?. Translat Neurosci 5 (2014), 51–56.
15. 15 Chételat, G., Villemagne, V.L., Bourgeat, P., et al. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol 67 (2010), 317–324.
16. 16 Wirth, M., Villeneuve, S., La Joie, R., et al. Gene–environment interactions: lifetime cognitive activity, APOE genotype, and beta-amyloid burden. J Neurosci 34 (2014), 8612–8617.
17. 17 Jansen, W., Ossenkoppele, R., Knol, D., et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 313 (2015), 1924–1938.
18. 18 Kryscio, R.J., Abner, E.L., Cooper, G.E., et al. Self-reported memory complaints: implications from a longitudinal cohort with autopsies. Neurology 83 (2014), 1359–1365.
19. 19 Snitz, B.E., Lopez, O.L., McDade, E., et al. Amyloid-β imaging in older adults presenting to a memory clinic with subjective cognitive decline: a pilot study. J Alzheimers Dis 48:suppl 1 (2015), S151–S159.
20. 20 Ebert, P.L., Anderson, N.D., Proactive and retroactive interference in young adults, healthy older adults, and older adults with amnestic mild cognitive impairment. J Int Neuropsychol Soc 15 (2009), 83–93.
21. 21 Hanseeuw, B.J., Seron, X., Ivanoiu, A., Increased sensitivity to proactive interference in amnestic cognitive impairment is independent of associative and semantic impairment. Brain Cogn 72 (2009), 325–33117.
22. 22 Loewenstein, D., Acevedo, A., Agron, J., et al. Stability of neurocognitive impairment in different subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord 23 (2007), 82–8618.
23. 23 Rodrigue, K.M., Kennedy, K.M., Devous, M.D. Sr, et al. β-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology 78 (2012), 387–395.
24. 24 Duara, R., Loewenstein, D., Shen, Q., et al. Amyloid positron emission tomography with (18)F- flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer's disease. Alzheimers Dement 9 (2013), 295–301.
25. 25 Rentz, D.M., Locasio, J.J., Becker, J.A., et al. Cognition, reserve and amyloid deposition in normal aging. Ann Neurol 67 (2009), 353–36421.